A clinical trial of piperazine oestrone sulphate (‘Harmogen’) in the treatment of menopausal symptoms
| Autor: | W Cooper, M Marnie, E Daw |
|---|---|
| Rok vydání: | 1974 |
| Předmět: |
Adult
medicine.medical_specialty Estrone medicine.medical_treatment Radioimmunoassay Physiology Hysterectomy Placebo Piperazines Placebos chemistry.chemical_compound Internal medicine medicine Humans Artificial menopause Estradiol Sulfates business.industry General Medicine Middle Aged medicine.disease Menopause Clinical trial Endocrinology chemistry Female Piperazine oestrone sulphate business hormones hormone substitutes and hormone antagonists |
| Zdroj: | Current Medical Research and Opinion. 2:260-263 |
| ISSN: | 1473-4877 0300-7995 |
| DOI: | 10.1185/03007997409115231 |
| Popis: | SummaryA clinical trial of piperazine oestrone sulphate (‘Harmogen’), the efficiency measured by the effect on plasma oestradiol levels, was conducted against a placebo in 20 patients who had undergone an artificial menopause. Clinical relief of symptoms correlated with the effect on the oestradiol levels. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|